| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $74.2M | -13.9% |
| Cost of Revenue | $845K | -69.4% |
| R&D Expense | $506.5M | -14.1% |
| SG&A Expense | $119.0M | -33.1% |
| Operating Income | -$587.2M | +14.2% |
| Pre-tax Income | -$523.1M | +16.7% |
| Income Tax | -$1.1M | +91.2% |
| Net Income | -$522.0M | +15.1% |
| EPS (Basic) | -$3.83 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $222.9M | -7.7% |
| Short-term Investments | $678.1M | -46.7% |
| Current Assets | $1.04B | -34.4% |
| Total Assets | $1.40B | -27.1% |
| Current Liabilities | $119.7M | -31.8% |
| Total Liabilities | $248.4M | -24.4% |
| Stockholders' Equity | $1.15B | -27.7% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$446.4M | +42.7% |
| Capital Expenditures | $7.3M | -66.2% |
| Investing Cash Flow | $499.4M | +203.3% |
| Financing Cash Flow | $4.4M | -41.3% |
| Free Cash Flow | -$453.7M | +43.3% |
| +16.6% |
| EPS (Diluted) | -$3.83 | +16.6% |